HRB
51
2
HPE
55
11
UHS
54
3
VLO
40
-2
EIX
77
2
STI
47
-12
MKC
56
8
USB
50
2
UPS
41
-4
NTAP
64
2
CVS
48
3
T
50
3
JNJ
41
2
NI
75
2
UA
45
-3
QRVO
6
2
IP
70
2
GRMN
62
-3
AA
51
3
UNH
61
6
HRB
51
2
HPE
55
11
UHS
54
3
VLO
40
-2
EIX
77
2
STI
47
-12
MKC
56
8
USB
50
2
UPS
41
-4
NTAP
64
2
CVS
48
3
T
50
3
JNJ
41
2
NI
75
2
UA
45
-3
QRVO
6
2
IP
70
2
GRMN
62
-3
AA
51
3
UNH
61
6
Financhill
Back

TransMedics Group 10K Form

Sell
41

TMDX
TransMedics Group

Last Price:
79.30
Seasonality Move:
34.24%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TMDX News And Ratings

See the #1 stock for the next 7 days that we like better than TMDX

TMDX Financial Statistics

Sales & Book Value

Annual Sales: $241.62M
Cash Flow: $-41.35M
Price / Cash Flow: 0
Annual Sales: $6.25
Price / Book: 12.94

Profitability

EPS (TTM): 0.94000
Net Income (TTM): $32.64M
Gross Margin: $154.09M
Return on Equity: 19.83%
Return on Assets: 4.46%

TransMedics Group Earnings Forecast

Key TransMedics Group Financial Ratios

  • The Gross Profit Margin over the past 8 years for TMDX is 63.77%.
  • The Selling, General & Administrative Expenses for TMDX have been equal to 49.48% of Gross Profit Margin.
  • The Research & Development expenses have been 26.18% of Revenue.
  • The Interest Expense is -43.12% of Operating Income.
  • The Net Earning history of TMDX is -10.36% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 5 years.

TransMedics Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: TMDX
CUSIP: 89377M
Website: transmedics.com

Debt

Debt-to-Equity Ratio: 2.42
Current Ratio: 8.2
Quick Ratio: 7

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 52.65

TMDX Technical Analysis vs Fundamental Analysis

Sell
41
TransMedics Group (TMDX) is a Sell

Is TransMedics Group a Buy or a Sell?

  • TransMedics Group stock is rated a Sell
    The current TransMedics Group [TMDX] share price is $77.20. The Score for TMDX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.